|
BBS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.026600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.694200E-01 |
| Normal-vs-Stage2 |
7.379200E-01 |
| Normal-vs-Stage3 |
8.140200E-01 |
| Normal-vs-Stage4 |
8.706400E-01 |
| Stage1-vs-Stage2 |
4.870200E-01 |
| Stage1-vs-Stage3 |
9.803800E-01 |
| Stage1-vs-Stage4 |
5.767000E-01 |
| Stage2-vs-Stage3 |
5.743200E-01 |
| Stage2-vs-Stage4 |
8.286800E-01 |
| Stage3-vs-Stage4 |
6.616600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.974600E-01 |
| Normal-vs-AfricanAmerican |
5.198000E-01 |
| Normal-vs-Asian |
4.810800E-01 |
| Caucasian-vs-AfricanAmerican |
5.091600E-01 |
| Caucasian-vs-Asian |
4.112200E-01 |
| AfricanAmerican-vs-Asian |
9.711800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.803600E-01 |
| Normal-vs-Female |
8.682400E-01 |
| Male-vs-Female |
1.324180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.014200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.386000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.520600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.431600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.497800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.224800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.471600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.673600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.002800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.001200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.544800E-01 |
| Classical-VS-Follicular |
1.826950E-04 |
| Classical-VS-Other |
1.902590E-01 |
| Classical-VS-Normal |
3.858000E-01 |
| Tall-VS-Follicular |
9.392200E-02 |
| Tall-VS-Other |
2.932400E-01 |
| Tall-VS-Normal |
9.240800E-01 |
| Follicular-VS-Other |
9.647200E-01 |
| Follicular-VS-Normal |
5.746400E-02 |
| Other-VS-Normal |
3.062200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.926200E-01 |
| Normal-vs-N1 |
5.562600E-01 |
| N0-vs-N1 |
8.531000E-01 |
|
|
